Most patients with chronic ischemia and an implantable cardiac defibrillator (ICD) for primary prevention do not experience therapies for ventricular arrhythmias on follow-up. The present study aimed to identify independent clinical, electrocardiographic, and echocardiographic predictors of death and occurrence of ICD therapy in patients with chronic ischemic cardiomyopathy and ICD for primary prevention. A total of 424 patients with chronic ischemic cardiomyopathy, ejection fraction ≤35%, and New York Heart Association (NYHA) clas
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
Background: Implantable cardioverter-defibrillator (ICD) therapy is considered appropriate when a pa...
Most patients with chronic ischemia and an implantable cardiac defibrillator (ICD) for primary preve...
Sudden cardiac death caused by sustained ventricular arrhythmia is the most common cause of death in...
The purpose of this study was to evaluate predictors of appropriate therapy in patients with implant...
Background An implantable cardioverter defibrillator (ICD) is recommended for patients with symptoma...
BackgroundConsidering morbidity and financial impact on the health care system, it may be helpful to...
BACKGROUND: When implantable cardioverter defibrillator (ICD) battery is depleted most patients unde...
ObjectivesThe purpose of this study was to define the incidence and predictors of implantable cardio...
BACKGROUND: When implantable cardioverter defibrillator (ICD) battery is depleted most patients unde...
Implantable cardioverter defibrillator (ICD) has been shown to be associated with a significant redu...
Background--Previous studies report conflicting results about a higher incidence of ventricular arrh...
Background When implantable cardioverter defibrillator (ICD) battery is depleted most patients under...
The necessity of implantable cardioverter-defibrillator (ICD) implantation in patients with systolic...
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
Background: Implantable cardioverter-defibrillator (ICD) therapy is considered appropriate when a pa...
Most patients with chronic ischemia and an implantable cardiac defibrillator (ICD) for primary preve...
Sudden cardiac death caused by sustained ventricular arrhythmia is the most common cause of death in...
The purpose of this study was to evaluate predictors of appropriate therapy in patients with implant...
Background An implantable cardioverter defibrillator (ICD) is recommended for patients with symptoma...
BackgroundConsidering morbidity and financial impact on the health care system, it may be helpful to...
BACKGROUND: When implantable cardioverter defibrillator (ICD) battery is depleted most patients unde...
ObjectivesThe purpose of this study was to define the incidence and predictors of implantable cardio...
BACKGROUND: When implantable cardioverter defibrillator (ICD) battery is depleted most patients unde...
Implantable cardioverter defibrillator (ICD) has been shown to be associated with a significant redu...
Background--Previous studies report conflicting results about a higher incidence of ventricular arrh...
Background When implantable cardioverter defibrillator (ICD) battery is depleted most patients under...
The necessity of implantable cardioverter-defibrillator (ICD) implantation in patients with systolic...
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients wit...
Background: Implantable cardioverter-defibrillator (ICD) therapy is considered appropriate when a pa...